Recombinant Human Tumor Necrosis Factor- α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout
Condition: Acute Gout Interventions: Drug: rhTNFR-Fc; Drug: Triamcinolone Acetonide Sponsor: Lihua Duan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
